GSK Links With OncoMed, Galapagos To Boost Oncologic, Anti-Infective Pipelines

Deals present possible $1.4 billion for OncoMed, €245 million for Galapagos through GSK’s external drug discovery centers.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet